MedPath

Clinical Outcomes With Bilateral Implantation of Odyssey IOLs

Completed
Conditions
Cataract
Interventions
Device: TECNIS Odyssey IOL
Registration Number
NCT06550375
Lead Sponsor
Mann Eye Institute
Brief Summary

This study is a single center, ambispective study of visual outcomes after successful bilateral cataract surgery. Subjects will be assessed at least 3 months postoperatively at a single visit. Clinical evaluations will include administration of the AIOLIS and OSDI questionnaires, as well as measurement of visual acuities at distance, intermediate, and near.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

• Patients aged 50 years and older who underwent bilateral cataract surgery with Odyssey IOL implantation.

Exclusion Criteria
  • Significant ocular comorbidities (e.g., macular degeneration, glaucoma).
  • < 2 weeks post YAG capsulotomy.
  • Best corrected distance visual acuity worse than 20/25.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TECNIS Odyssey IOLTECNIS Odyssey IOL-
Primary Outcome Measures
NameTimeMethod
Visual Acuity at Near (40cm) logMAR3 months postoperative

Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected

Visual Acuity at Near (33cm) logMAR3 months postoperative

Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected

Visual Acuity at Distance (6m) logMAR3 months postoperative

Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected

Visual Acuity at Intermediate (66cm) logMAR3 months postoperative

Photopic and mesopic, binocular and monocular, and uncorrected and distance corrected

Secondary Outcome Measures
NameTimeMethod
Assessment of IntraOcular Lens Implant Symptoms (AIOLIS) Questionniare3 months postoperative

The AIOLIS has 37 questions about symptoms, perceptions of general vision, and frequency of wearing glasses or contact lenses. Lower scores for the symptom questions indicate lower frequency and both of visual disturbances.

Trial Locations

Locations (1)

Mann Eye Institute

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath